To MediSwipe Shareholders:
I am pleased to update the investment community and other interested parties on the progress to date of MediSwipe Inc. and our corporate strategy as we move forward into 2012. We have been working closely with all our strategic partners and clients to advance the interests of the Company on behalf of our shareholders. As you are aware, near the
end of 2011, there were numerous events on both the legislative and banking side within the medicinal and alternative health sector that caused us to modify our business model and seek vertical markets to remain a viable company. It takes more than six months to build a solid business model within a sector subject to monthly legislative changes.
I have always believed the company offers industry changing technology , and the time is now ripe for our industry to embrace our functionality through the solutions and partnerships we have built within the healthcare and payment industries. I continue to be impressed by the clear advantage in functionality that the MediSwipe solutions have over
any competing solution in the financial payments market, and our strategy of building partnerships with industry leaders will soon begin to yield meaningful revenue results. In addition, we have expanded our relationships with our existing client base significantly in late 2011 and early 2012 and anticipate our revenue will increase markedly as a
result of these efforts. We expect that all of our activities last year will combine to deliver greatly improved results in 2012.
With regard to the pending S-1 registration of our division 800 Commerce, while it was the intentions of management to complete this registration before year end, we were delayed by proposed acquisitions as part of the filing, and a last decision by our independent auditing firm to include December 2011 financials as part of the filing for two years completed financials. Although disappointing, it is typical in for negotiations and such comprehensive auditing reports to continue beyond the deadlines in order to reach mutually acceptable and workable resolutions. Regardless, MWIP has now completed the two year financial reports for 800 commerce, submitted them to our auditor, and the filing
is forthcoming as promised. The 8-K filing was not necessary as we had not changed primary auditors, simply added an additional firm for the 800 Commerce audits. We have been approved and received a CUSIP number for the Spin-off to issue certificates to our shareholders once effective, and will file the form 15C-211 simultaneously for a separate
symbol with the S-1 filing. We will keep shareholders updated in a timely manner once the filing date is reached.
Sales
Our merchant processing volume has remained constant, despite what has happened within the medicinal sector in California and Colorado. With the recent breakthrough in Arizona, we expect to attack the area aggressively with our payment card solution, as MediSwipe was featured as the major technology partner in the Arizona Business Journal last
year as a primary financial partner for the industry.
Technology
Our new mobile payment, gift and loyalty solution through technology partners will prove to be a major revenue source throughout 2012 as an alternative payment solution, not only within the healthcare sector, but to small business as well with its’ mobile coupon, gift and SMS offering features.
Partnerships
We have signed several new agreements with details to be announced over the next few weeks that will grow our company within the healthcare sector beyond payment solutions and utilize our network of pharmacies and wellness centers, including private labeled nutraceutical product lines and online sales of existing products through our 800 Commerce e-shopping cart systems. World demand for nutraceutical ingredients is projected to increase more than 7% percent annually to nearly $24 billion in 2015.
Additionally, on the 800 Commerce side, we have signed agreements for SMS messaging technologies and IVR technology that will enable us to become a major competitor in the mobile health space for medical alerts
and bill pay. Details on these agreements will be released in the next short weeks.
We also plan to continue our aggressive acquisition campaign, and believe that we have targeted our potential partner which will take the place of our initial VestaDigital plan, that will allow us to pursue the social media component of healthcare, which we believe will prove to be a very important aspect of the future of healthcare.
If you have questions, please ask the Company directly through its investor relations representative, 615.252.4099 ext. 103. Merchants interested in more information on the merchant processing, mobile payment and the nutraceutical line for their business should contact the Company at 615.252.4099 ext. 101
“We would like to thank our shareholders for their continued patience and appreciate the confidence you have extended to the company.”
Respectfully,
B. Michael Friedman
To MediSwipe Shareholders: I am pleased to update the
Top 10 Most Recent News Articles
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data
Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...
Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations
ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...
Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms
Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...
Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control
Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...
Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined
Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...
Continue Reading
Uber Data Breach: Class Action Investigation Begins
When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...
Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit
A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...
Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup
An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....
Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly
Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...
Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries
JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...
Continue ReadingTop 5 Most Recently Viewed Articles
Leadership Transition at Ignitis Renewables Sparks Future Growth
Leadership Transition at Ignitis Renewables AB “Ignitis grup?” has announced a significant change in leadership with the resignation of Thierry Aelens, the Chief Executive Officer (CEO) of its subsidiary, UAB “Ignitis Renewables.” Aelens will step down effective at the end of March 2025 for personal reasons and to pursue new career opportunities nearer to his...
Continue Reading
Katalyze AI Elevates Innovation with New Chief AI Officer
Advancing Pharmaceutical Manufacturing with AI Leadership Katalyze AI has recently announced a pivotal move to strengthen its capabilities in the fast-evolving field of pharmaceutical manufacturing. The company has appointed Hannes Bretschneider as Chief AI Officer, signaling its commitment to advancing Agentic AI architecture. This strategic initiative aims to enhance...
Continue Reading
Iran's Strait Closure: Defense Stocks on Edge Amid Shipping Risks
Iran announced the temporary closure of the Strait of Hormuz for live-fire drills, raising eyebrows across trading desks. This isn't just a geopolitical stunt; it’s a shot across the bow at U. S. military presence in the region, occurring right as indirect nuclear talks unfold with Washington. A maneuver like this sends ripples through markets that thrive on stability,...
Continue Reading
Aphaia Pharma's Engagement in Revolutionary Obesity Forum
Aphaia Pharma's Engagement in Revolutionary Obesity Forum Aphaia Pharma, a leading clinical-stage biopharmaceutical company, is making waves in the field of treatments for obesity and related metabolic disorders. The company has announced that its Chief Scientific Officer, Dr. Steffen-Sebastian Bolz, will share insights during a panel discussion at the much-anticipated...
Continue Reading
U.S. Strives to Diminish China's Dominance in Rare Earths
Understanding the Importance of Rare Earth Elements In recent discussions, the significance of rare earth elements (REEs) has come to the forefront of international policy. These elements play a crucial role in various sectors, from technology to defense. Currently, China holds a dominant position in the production and refinement of these vital minerals, controlling...
Continue Reading